The prognostic value of the cardiopulmonary exercise test in patients with heart failure who have been treated with beta-blockers

Turk Kardiyoloji Dernegi Arsivi

Volumn 41, Issue 2, 2013, Pages 105-112

  Dufay Bougon, Clémentine ^a   Belin, Annette ^a   Dahdouh, Ziad Said ^a   Barthelemy, Sophie ^b   Mabire, Jean Paul ^c   Sabatier, Ŕemi ^a   Milliez, Paul ^a   Grollier, Gilles ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Clinique de la Miséricorde   (France)

^c Department of Cardiac Rehabilitation Hospital of Côte Fleurie   (France)

Author keywords

Adrenergic beta antagonists therapeutic use; Heart failure drug therapy; Oxygen consumption physiology; Predictive value of tests; Prognosis

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARBON DIOXIDE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART REHABILITATION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PREDICTOR VARIABLE; PROGNOSIS; RETROSPECTIVE STUDY; AGE DISTRIBUTION; AGED; DRUG COMBINATION; EXERCISE TEST; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; SEX RATIO;

ADRENERGIC BETA-ANTAGONISTS; AGE DISTRIBUTION; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBON DIOXIDE; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; SEX DISTRIBUTION; STROKE VOLUME;

EID: 84876743018     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2013.87404     Document Type: Article

References (29)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
2. Task Force of the Italian Working Group on Cardiac Rehabilitation and Prevention (Gruppo Italiano di Cardiologia Riabilitativa e Prevenzione, GICR); Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology, Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006;13:300-11.
3. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
4. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004;147:354-60. (Pubitemid 38176838)
5. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000;21:154-61. (Pubitemid 30072630)
6. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000;101:2803-9. (Pubitemid 30396010)
7. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 2002;23:806-14. (Pubitemid 35238495)
8. Lund LH, Aaronson KD, Mancini DM. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol 2003;92:1350-4. (Pubitemid 37431152)
9. Tabet JY, Beauvais F, Thabut G, Tartière JM, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VC02 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2003;10:267-72.
10. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7. (Pubitemid 16066969)
11. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984;129:S49-55. (Pubitemid 14190983)
12. Williams SG, Jackson M, Cooke GA, Barker D, Patwala A, Wright DJ, et al. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure? Am Heart J 2005;150:983.
13. Arena R, Guazzi M, Myers J, Peberdy MA. Prognostic value of heart rate recovery in patients with heart failure. Am Heart J2006;151:851.e7-13.
14. Van Laethem C, Bartunek J, Goethals M, Nellens P, Andries E, Vanderheyden M. Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. Am Heart J 2005;149:175-80. (Pubitemid 40126506)
15. Guazzi M, De Vita S, Cardano P, Bariera S, Guazzi MD. Normalization for peak oxygen uptake increases the prognostic power of the ventilatory response to exercise in patients with chronic heart failure. Am Heart J 2003;146:542-8. (Pubitemid 37083092)
16. Zugck C, Haunstetter A, Krüger C, Kell R, Schellberg D, K̈gbier W, et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 2002;39:1615-22. (Pubitemid 34494284)
17. Peterson LR, Schechtman KB, Ewald GA, Geltman EM, Meyer T, Krekeler P, et al. The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant 2003;22:70-7. (Pubitemid 36071419)
18. Pohwani AL, Murali S, Mathier MM, Tokarczyk T, Kormos RL, McNamara DM, et al. Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 2003;22:78-86. (Pubitemid 36071420)
19. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am Heart J 2000;139:78-84. (Pubitemid 30043628)
20. Shakar SF, Lowes BD, Lindenfeld J, Zolty R, Simon M, Robertson AD, et al. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. J Card Fail 2004;10:15-20. (Pubitemid 38880887)
21. Corrà U, Mezzani A, Bosimini E, Scapellato F, Temporelli PL, Eleuteri E, et al. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol. Am Heart J 2004;147:553-60. (Pubitemid 38880882)
22. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 2005;111:2313-8. (Pubitemid 40647066)
23. Scharf C, Merz T, Kiowski W, Oechslin E, Schalcher C, Brunner-La Rocca HP. Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure. Chest 2002;122:1333-9. (Pubitemid 35339549)
24. Tabet JY, Metra M, Thabut G, Logeart D, Cohen-Solal A. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy. Am J Cardiol 2006;98:500-3. (Pubitemid 44162878)
25. Andersson B, Hamm C, Persson S, Wikström G, Sinagra G, Hjalmarson A, et al. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994;23:1397-404. (Pubitemid 24158009)
26. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90. (Pubitemid 27272454)
27. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001;103:967-72. (Pubitemid 32183802)
28. Arena RA, Guazzi M, Myers J, Abella J. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure. Med Sci Sports Exerc 2007;39:213-9. (Pubitemid 46204286)
29. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure. Chest 2003;124:720-7. (Pubitemid 37000154)